Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc

NCT04119882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 404

Last updated 2021-09-28

No results posted yet for this study

Summary

The objective of the study is to assess the performance characteristics of Apo J-Glyc as a novel biomarker for the early detection of myocardial ischaemia in patients with suspected acute coronary syndromes.

Conditions

  • Myocardial Ischemia

Interventions

DIAGNOSTIC_TEST

Blood collection

New biomarker test

Sponsors & Collaborators

  • Glycardial Diagnostics S.L.

    lead INDUSTRY

Principal Investigators

  • Judit Cubedo · Glycardial Diagnostics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-20
Primary Completion
2021-02-10
Completion
2021-09-20

Countries

  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04119882 on ClinicalTrials.gov